2008
DOI: 10.1038/ncponc1070
|View full text |Cite
|
Sign up to set email alerts
|

Systems medicine in oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Systems approaches are becoming increasingly popular in applied oncology [3] and other medical settings [1]. Today, many authors combine a molecular perspective with approaches that rely on the dynamics of intracellular structures on larger size and timescales or that rely on the way whole cells are organized in tissues.…”
Section: The General Systems Perspective In Medicinementioning
confidence: 99%
“…Systems approaches are becoming increasingly popular in applied oncology [3] and other medical settings [1]. Today, many authors combine a molecular perspective with approaches that rely on the dynamics of intracellular structures on larger size and timescales or that rely on the way whole cells are organized in tissues.…”
Section: The General Systems Perspective In Medicinementioning
confidence: 99%
“…It tries to understand perturbed physiological systems and complex pathologies in their entirety by integrating all levels of quantitative functional, structural, and morphological information into a coherent model. In contrast to systems biology, systems medicine seeks an integrative and systemic approach for the diagnosis, therapy, and prevention of diseases [47]. It investigates the physiological network of diseases from gene to organ systems with four main goals -predictive, preventive, personalized, and participative medicine (P4 medicine).…”
Section: Systems Biology and Medicinementioning
confidence: 99%
“…However, studies have consistently demonstrated that this simple framework is inefficient in addressing drug action in complex and multi-factorial disease systems. In such systems, limiting drug research to targeting single disease biomarkers is one of the main causes of drug failures in clinical trials 1, 2, 40 . Drug induced reprogramming of cellular responses is directed through metabolic reactions, which are regulated by signaling pathways enormously enriched in protein-protein interactions.…”
Section: Resultsmentioning
confidence: 99%
“…Regan-Fendt et al 66 recently developed a computational drug combination analysis using transcriptome data and disease specific root genes for malignant melanoma and successfully predicted vemurafenib and tretinoin as synergistic therapeutic combinations. Variants of this approach, for instance, modelling the active drug subnetworks using deep learning, could be applied to systematically predict combinations and side-effects for precision medicine applications in complex diseases 40, 45 .…”
Section: Discussionmentioning
confidence: 99%